Literature DB >> 18809798

Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling.

Paula A da Costa Martins1, Meriem Bourajjaj, Monika Gladka, Mara Kortland, Ralph J van Oort, Yigal M Pinto, Jeffery D Molkentin, Leon J De Windt.   

Abstract

BACKGROUND: Dicer, an RNAse III endonuclease critical for processing of pre-microRNAs (miRNAs) into mature 22-nucleotide miRNAs, has proven a useful target to dissect the significance of miRNAs biogenesis in mammalian biology. METHODS AND
RESULTS: To circumvent the embryonic lethality associated with germline null mutations for Dicer, we triggered conditional Dicer loss through the use of a tamoxifen-inducible Cre recombinase in the postnatal murine myocardium. Targeted Dicer deletion in 3-week-old mice provoked premature death within 1 week accompanied by mild ventricular remodeling and dramatic atrial enlargement. In the adult myocardium, loss of Dicer induced rapid and dramatic biventricular enlargement, accompanied by myocyte hypertrophy, myofiber disarray, ventricular fibrosis, and strong induction of fetal gene transcripts. Comparative miRNA profiling revealed a set of miRNAs that imply causality between miRNA depletion and spontaneous cardiac remodeling.
CONCLUSIONS: Overall, these results indicate that modifications in miRNA biogenesis affect both juvenile and adult myocardial morphology and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809798     DOI: 10.1161/CIRCULATIONAHA.108.769984

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  125 in total

1.  The RNase III enzyme DROSHA is essential for microRNA production and spermatogenesis.

Authors:  Qiuxia Wu; Rui Song; Nicole Ortogero; Huili Zheng; Ryan Evanoff; Chris L Small; Michael D Griswold; Satoshi H Namekawa; Helene Royo; James M Turner; Wei Yan
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  MicroRNAs: Novel Regulators of the Heart.

Authors:  Junjie Xiao; Yi-Han Chen
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

Review 3.  Therapeutic potential of microRNAs in heart failure.

Authors:  Gerald W Dorn
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

4.  MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function.

Authors:  Sebastian Albinsson; Yajaira Suarez; Athanasia Skoura; Stefan Offermanns; Joseph M Miano; William C Sessa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-08       Impact factor: 8.311

Review 5.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

6.  MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development.

Authors:  Auinash Kalsotra; Kun Wang; Pei-Feng Li; Thomas A Cooper
Journal:  Genes Dev       Date:  2010-03-18       Impact factor: 11.361

Review 7.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

Review 8.  MicroRNAs: redefining mechanisms in cardiac disease.

Authors:  Gerald W Dorn
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

Review 9.  MicroRNAs and cardiac pathology.

Authors:  Michael V G Latronico; Gianluigi Condorelli
Journal:  Nat Rev Cardiol       Date:  2009-06       Impact factor: 32.419

10.  microRNA expression profiling and functional annotation analysis of their targets modulated by oxidative stress during embryonic heart development in diabetic mice.

Authors:  Daoyin Dong; Yuji Zhang; E Albert Reece; Lei Wang; Christopher R Harman; Peixin Yang
Journal:  Reprod Toxicol       Date:  2016-09-11       Impact factor: 3.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.